Double-Blind, Crossover Design * |
Volunteer #'s |
Phase I |
Phase II |
# 1 thru # 6 |
b-Carotene+
placebo |
b-Carotene+
BioPerine® |
# 7 thru # 12 |
b-Carotene+
BioPerine® |
bb-Carotene+
placebo |
* Phase I & Phase II supplementation periods occurred 12 weeks apart.
Treatment |
Baseline |
Day 14 |
Change |
bb-Carotene+
placebo |
66.0 + 11.5 |
65.1 + 10.2 |
-0.9 + 2.4 |
b-Carotene+
BioPerine® |
65.2 + 11.9 |
65.0 + 10.6 |
-0.2 + 2.1 |
Comparisons (baseline vs. Day 14, placebo vs. BioPerine® at Day 14, placebo vs. BioPerine® change at Day 14) indicated no statistically significant differences.
Disclaimer
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
